JPRN-jRCT1041190094尚未招募未知
Verification of efficacy and safety of bisphosphonates or denosumab for patients with osteoporosis after treatment with romosozumab
Kobayakawa Tomonori0 个研究点目标入组 100 人开始时间: 2019年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 100age old（—）
- 性别
- All
入选标准
- •1. Primary osteoporosis
- •2. Patients who used romosozumab for 12 months
- •3. Written informed consent
排除标准
- •1.Patients who are allergic to lomosozumab and ibandronate
- •2.hypocalcemia
- •3.Pregnant or breastfeeding women
- •4.Patients with reflux esophagitis, esophageal achalasia
- •5.Patients who cannot keep standing or sitting for more than 60 minutes
- •6.GFR30mL/min/1.73m2 or less, Dialysis patients
- •7.Patients with upper gastrointestinal disorders such as dysphagia, esophagitis, gastritis, duodenal
- •inflammation, ulcers
- •8.Patients judg ed to be inappropriate for study
研究者
相似试验
招募中
2 期
This is a randomised study to assess the safety and efficacy of a combined drug and orthopaedic standard care compared to the standard orthopaedic care and treatment for Perthes Disease in children.Avascular Necrosis due to Perthes Disease.Musculoskeletal - Other muscular and skeletal disordersACTRN12610000407099The Royal Alexandria Hospital for Children140
招募中
不适用
Osteoporosis during MenopauseCTRI/2018/02/011964DEPARTMENT OF ENDOCRINOLOGY
招募中
2 期
Evaluation of Usefulness of BP for DSODiffuse Sclerosing Osteomyelitis of the jawDSOJPRN-jRCTs011180002Kitagawa Yoshimasa13
尚未招募
不适用
Bisphosphonate therapy in idiopathic avascular necrosis of femoral head in adolescents and young adults.CTRI/2022/10/046412Department of Orthopedics40
招募中
不适用
Evaluation of Usefulness of Bisphosphanate for diffuse sclerosing osteomyelitis of the jawDiffuse Sclerosing Osteomyelitis of the jawJPRN-UMIN000032089Hokkaido University13